HRSA-21-102: Rural Residency Planning and Development Technical Assistance Program
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2021.
Health Resources and Services Administration offered grants to the applicants described in the notice. It expected to make one award worth $4.3 million in total. Applications closed on May 21, 2021.
From the official notice on Grants.gov, last changed April 9, 2021. Checked November 7, 2026.
- Total funding$4.3 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | April 9, 2021 |
|---|---|
| Deadline | May 21, 2021 |
| Archived by Grants.gov | July 20, 2021 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants are domestic public or private, non-profit entities, including faith-based and community-based organizations, tribes and tribal organizations, institutions of higher education, state and local governments, and hospitals. Recipients of the RRPD Program (HRSA-19-088 and HRSA-20-107) are not eligible to receive funding under this notice. Similarly, the RRPD-TA award recipient will not be eligible for funding under the RRPD Program, contingent on future funding opportunities.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity to apply for funding under the Health Resources and Services Administration (HRSA) Rural Residency Planning and Development Technical Assistance (RRPD-TA) Program. The purpose of this cooperative agreement is to provide technical assistance (TA) to HRSA’s Rural Residency Planning and Development (RRPD) Program award recipients to support the creation of new rural residency programs that will expand the rural physician workforce. The RRPD-TA award recipient will provide TA, tools and resources to current and future RRPD Program award recipients to help overcome significant challenges and barriers involved in developing new rural residency programs. The priority for TA will be RRPD Program award recipients. However, limited TA resources may be publicly available for other entities interested in developing new rural residency programs. For the purposes of this notice of funding opportunity, rural residencies are allopathic and osteopathic physician residency programs in specialties as determined by HRSA that primarily train residents in rural clinical settings and focus on producing physicians who will practice in rural communities. Rural residencies may be rurally located or integrated with a separately accredited program within a larger, urban residency program, also known as a rural training track (RTT). In FY 2018, HRSA funded a three-year cooperative agreement (HRSA-18-117) to establish a RRPD-TA center to identify and share resources with RRPD applicants and support RRPD Program award recipients. Thereafter, HRSA funded 27 (HRSA-19-088) organizations in FY 2019, up to $750,000 per award, for a three-year period of performance to develop new, accredited, and sustainable rural residency programs. An additional 11 organizations were awarded funding in FY 2020 (HRSA-20-107) to develop rural residency programs in family medicine, internal medicine, psychiatry, obstetrics and gynecology (OB/GYN), general surgery, and public health and general preventive medicine (hereafter referred to as “preventive medicine”). RRPD Program award recipients may use their funding for recruiting residency program directors, faculty/staff development, accreditation, resident recruitment, and developing graduate tracking systems.
Who has won Rural Health Research Centers grants before
From fiscal 2021 to 2025, Rural Health Research Centers (93.155) awarded $615 million across 341 grant awards, an average of $1.8 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Texas Department of Agriculture | Texas | 1 | $28.8 million |
| Kansas Department of Health & Environment | Kansas | 1 | $21.4 million |
| Iowa Department of Public Health | Iowa | 1 | $16.4 million |
| Minnesota Department of Health | Minnesota | 1 | $16.3 million |
| Department of Public Health Illinois | Illinois | 1 | $15.8 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-21-102 still open?
No. It closed on May 21, 2021.
Who can apply for Rural Residency Planning and Development Technical Assistance Program?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Rural Residency Planning and Development Technical Assistance Program?
Closed May 21, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $4.3 million in total for one award.
Who has won Rural Health Research Centers grants before?
The largest recipients over five fiscal years were Texas Department of Agriculture, Kansas Department of Health & Environment, Iowa Department of Public Health. The program made 341 awards worth $615 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)